Adding subcutaneous liraglutide to metformin reduces HbA1c more than adding oral sitagliptin in patients whose type 2 diabetes is poorly controlled with metformin alone

Vivian Fonseca, Cyrus V Desouza, Amna N. Khan

Research output: Contribution to journalComment/debate

2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)115-116
Number of pages2
JournalEvidence-Based Medicine
Volume15
Issue number4
DOIs
StatePublished - Aug 1 2010

Fingerprint

Metformin
Type 2 Diabetes Mellitus
Liraglutide
Sitagliptin Phosphate

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{e3849e3916b74bc68eaceb7ca6e46ebd,
title = "Adding subcutaneous liraglutide to metformin reduces HbA1c more than adding oral sitagliptin in patients whose type 2 diabetes is poorly controlled with metformin alone",
author = "Vivian Fonseca and Desouza, {Cyrus V} and Khan, {Amna N.}",
year = "2010",
month = "8",
day = "1",
doi = "10.1136/ebm1098",
language = "English (US)",
volume = "15",
pages = "115--116",
journal = "Evidence-Based Medicine",
issn = "1356-5524",
publisher = "BMJ Publishing Group",
number = "4",

}

TY - JOUR

T1 - Adding subcutaneous liraglutide to metformin reduces HbA1c more than adding oral sitagliptin in patients whose type 2 diabetes is poorly controlled with metformin alone

AU - Fonseca, Vivian

AU - Desouza, Cyrus V

AU - Khan, Amna N.

PY - 2010/8/1

Y1 - 2010/8/1

UR - http://www.scopus.com/inward/record.url?scp=77955252981&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955252981&partnerID=8YFLogxK

U2 - 10.1136/ebm1098

DO - 10.1136/ebm1098

M3 - Comment/debate

C2 - 20610447

AN - SCOPUS:77955252981

VL - 15

SP - 115

EP - 116

JO - Evidence-Based Medicine

JF - Evidence-Based Medicine

SN - 1356-5524

IS - 4

ER -